Thursday 10th September
09:10 to 09:20
The role of the interdisciplinary "Aortic Team" in optimising the emergency transfer of patients and its impact on outcome
Marcus Brooks, North Bristol NHS Trust, UK
09:20 to 09:30
Imaging surveillance after Type B dissection: How often, what to look for, and what we may be missing
Federica Catapano, Humanitas Research Hospital, Milan, Italy
Federica Catapano
09:30 to 09:40
Contemporary analysis techniques for the multimodal data and how it can inform the management of Type B aortic dissection
Kak Khee Yeung, University of Amsterdam, Netherlands
Kak Khee Yeung
09:40 to 09:50
Guidelines vs reality: Where evidence fails in Type B aortic dissection
Anders Wanhainen, University of Uppsala, Sweden
Anders Wanhainen
09:50 to 10:05
Perspectives on survivorship and surveillance
Martin Hilton, Patient representative, Aortic Dissection Charitable Trust
Tara Mastracci, Barts Health, London, UK
Tara Mastracci , Martin Hilton
10:05 to 10:30
Discussion
10:30 to 10:45
Endovascular reconstruction of the dissected ascending aorta and arch: Defining strategy in the era of fenestrated and branched repair and what comes next
Speaker: Stéphan Haulon, Hopital Marie Lannelongue, Paris, France
Introduced by Vishy Mahadevan, Emeritus Professor Of Surgical Anatomy, Royal College of Surgeons of England
Vote of thanks by Tara Mastracci
Stephan Haulon
11:15 to 11:25
From open to hybrid to total endovascular: Navigating the transition in the treatment of the dissected aortic arch
Nimesh Desai, University of Pennsylvania, USA
Nimesh Desai
11:25 to 11:35
Do we need a more effective solution for chronic false lumen sac management?
Gustavo Oderich, Baylor Medicine Centre for Aortic Surgery, USA
Gustavo Oderich
11:35 to 12:15
Strategy & Future Scoping Roundtable
Lead discussant: Tim Resch, University of Copenhagen, Denmark
Expert panel: Anders Wanhainen, Stéphan Haulon, Nimesh Desai, Eric Roselli, Tara Mastracci, Kak Khee Yeung
- Remote monitoring in aortic dissection
- Is remodelling for chronic dissection important and, if so, how can we achieve it?
- Functional and haemodynamic assessment of the dissected aorta, with potential AI integration
- Endovascular technologies in connective tissue disease
12:15 to 12:35
Integrated Aortic Team Debate
Convenors: Tara Mastracci & Barend Mees
Panel: Nimesh Desai, Eric Roselli, Stéphan Haulon & Gustavo Oderich
One Aorta. Four Experts. One decision?
Each expert present, defends and critiques their preferred open or endovascular strategy for the same complex aortic dissection
Tara Mastracci , Barend Mees , Nimesh Desai , Eric Roselli , Stéphan Haulon , Gustavo Oderich
12:35 to 12:45
Cook Medical Guest Lecture: Patient-specific solutions for complicated Type B dissection: A complete endovascular portfolio
Tara Mastracci
13:35 to 13:50
Off-the-shelf endovascular solutions will replace custom and physician-modified devices in aortic dissection
For: Tim Resch, University of Copenhagen, Denmark
Against: Gustavo Oderich, Baylor Medicine Centre for Aortic Surgery, USA
Tim Resch , Gustavo Oderich
13:50 to 14:00
Malperfusion in Type A aortic dissection: When, how and what to fix first
Eric Roselli, Cleveland Clinic, USA
Eric Roselli
14:00 to 14:10
The hostile access: Navigating true lumen collapse, iliac malperfusion, and the inaccessible branch vessel
Barend Mees, Maastricht Heart+Vascular Center, Maastricht, Netherlands
Barend Mees
14:10 to 14:20
Complications of TEVAR in dissection: Risk factors, prevention, recognition and bailout strategies
Stephen Cheng, University of Hong Kong
Stephen Cheng
14:20 to 14:40
Discussion
14:40 to 15:10
Interactive MDT simulation in conjunction with the European Vascular Course
Chair: Barend Mees
Cases for discussion: Becky Sandford & Mohamed Abdelhalim
Expert panel: Judith Partridge, Panos Gkoutzios, Eric Roselli, Colin Bicknell, Michael Sabetai, Stephen Cheng
Barend Mees , Becky Sandford , Jude Partridge , Panos Gkoutzios , Eric Roselli , Colin Bicknell , Michael Sabetai , Stephen Cheng
15:10 to 15:20
Gore Guest Lecture: Optimising Aortic Arch Treatment: Clinical Experience with the GORE® TAG® Thoracic Branch Endoprosthesis
David Murray, Manchester Vascular Centre, Manchester Royal Infirmary, UK
15:50 to 16:10
Global roundtable on evidence for managing uncomplicated Type B dissection
3 minute update on uncomplicated TBAD trials
Moderator: Kevin Mani
Panel: Firas Mussa, Colin Bicknell, Jacob Budtz-Lilly
Discussion points:
- Medical optimisation, how is this being achieved in practice in the trials?
- Does device choice and timing of intervention really change outcomes?
- What are we learning from the patients not included in the trials? Data from screening
- How generalisable are these trials - management of dissections and centres of expertise
16:10 to 16:25
IMH is not a separate disease: It should be treated the same as dissection
For: Firas Mussa, UTHealth Houston McGovern Medical School, USA
Against: Jacob-Budtz-Lilly, Aarhus University, Denmark
Firas Mussa , Jacob Budtz-Lilly
16:25 to 16:40
When treatment creates the next problem
- Distal stent-induced new entry (dSINE): Kak Khee Yeung, University of Amsterdam, Netherlands
- Extensive aortic coverage and altering stiffness: Anders Wanhainen, University of Uppsala, Sweden
16:40 to 16:50
The STABILISE registry: What have we learnt?
Germano Melissano, "Vita-Salute” San Raffaele, University of Milan, Italy
Germano Melissano
16:50 to 17:00
Trends in epidemiology and outcome of aortic dissections - a national population-based study
Kevin Mani, Uppsala University, Sweden
Kevin Mani
17:00 to 17:25
Discussion